Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DAROLUTAMIDE for Metastasis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 18 adverse event reports in the FDA FAERS database where DAROLUTAMIDE was used for Metastasis.

Most Reported Side Effects for DAROLUTAMIDE

Side Effect Reports % Deaths Hosp.
Fatigue 384 11.8% 11 62
Death 361 11.1% 359 23
Hot flush 203 6.3% 4 26
Asthenia 173 5.3% 8 49
Prostatic specific antigen increased 156 4.8% 9 23
Off label use 133 4.1% 10 30
Neuropathy peripheral 127 3.9% 0 12
Diarrhoea 122 3.8% 4 25
Dizziness 122 3.8% 3 28
Rash 116 3.6% 5 17
Arthralgia 115 3.5% 3 22
Nausea 111 3.4% 1 32
Dyspnoea 109 3.4% 8 41
Pain in extremity 106 3.3% 4 32
Decreased appetite 105 3.2% 7 34

Other Indications for DAROLUTAMIDE

Prostate cancer (990) Hormone-refractory prostate cancer (553) Hormone-dependent prostate cancer (294) Prostate cancer metastatic (200) Product used for unknown indication (193) Metastases to bone (31) Metastases to lymph nodes (11) Metastases to lung (9) Prostate cancer stage iv (8) Neoplasm malignant (6)

Other Drugs Used for Metastasis

CABOZANTINIB S-MALATE (225) BINIMETINIB (172) ENCORAFENIB (168) CARBOPLATIN (114) CAPECITABINE (109) PACLITAXEL (101) BEVACIZUMAB (97) FLUOROURACIL (96) DABRAFENIB (93) TRAMETINIB DIMETHYL SULFOXIDE (93)

Related Pages

DAROLUTAMIDE Full Profile All Metastasis Drugs DAROLUTAMIDE Demographics DAROLUTAMIDE Timeline